Ausgabe 8/2019
Inhalt (10 Artikel)
Targeting α-Synuclein in Parkinson’s Disease: Progress Towards the Development of Disease-Modifying Therapeutics
Daniel Savitt, Joseph Jankovic
Dacomitinib in the Management of Advanced Non-Small-Cell Lung Cancer
Sally C. M. Lau, Ullas Batra, Tony S. K. Mok, Herbert H. Loong
Adverse Effects Associated with Long-Term Administration of Azole Antifungal Agents
Lydia L. Benitez, Peggy L. Carver
Does the Administration of Sevelamer or Nicotinamide Modify Uremic Toxins or Endotoxemia in Chronic Hemodialysis Patients?
Aurelie Lenglet, Nicolas Fabresse, Méline Taupin, Cathy Gomila, Sophie Liabeuf, Said Kamel, Jean Claude Alvarez, Tilman B. Drueke, Ziad A. Massy
Tafamidis: A Review in Transthyretin Amyloidosis with Polyneuropathy
Yvette N. Lamb, Emma D. Deeks
Teriflunomide: A Review in Relapsing–Remitting Multiple Sclerosis
Lesley J. Scott
Correction to: Pegaspargase: A Review in Acute Lymphoblastic Leukaemia
Young-A. Heo, Yahiya Y. Syed, Susan J. Keam